BARCLAYS PLC - MEREO BIOPHARMA GROUP PLC ownership

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of MEREO BIOPHARMA GROUP PLC
ValueSharesWeighting
Q3 2023$076
+100.0%
0.00%
Q2 2023$0
-100.0%
38
-100.0%
0.00%
Q1 2023$134
+7.2%
190,007
+14.0%
0.00%
Q4 2022$125
-99.6%
166,641
+322.2%
0.00%
Q3 2022$34,000
+54.5%
39,470
+97.4%
0.00%
Q2 2022$22,000
-95.4%
20,000
-95.3%
0.00%
Q1 2022$477,000
-60.0%
426,085
-42.9%
0.00%
Q4 2021$1,192,000
+2383.3%
745,588
+3627.9%
0.00%
Q3 2021$48,000
-23.8%
20,0000.0%0.00%
Q2 2021$63,000
-76.3%
20,000
-74.7%
0.00%
Q1 2021$266,00078,988
+987250.0%
0.00%
Q2 2019$080.00%
Other shareholders
MEREO BIOPHARMA GROUP PLC shareholders Q4 2023
NameSharesValueWeighting ↓
Rubric Capital Management LP 16,756,120$18,767,0000.99%
Clearline Capital LP 3,058,596$3,426,0000.44%
SUVRETTA CAPITAL MANAGEMENT, LLC 9,142,067$10,239,0000.39%
DAFNA Capital Management LLC 1,096,513$1,228,0000.34%
Octagon Capital Advisors LP 1,000,000$1,120,0000.30%
Rock Springs Capital Management LP 6,230,275$6,978,0000.20%
Boxer Capital, LLC 2,250,000$2,520,0000.16%
Orbimed Advisors 7,109,954$7,963,0000.14%
Artal Group S.A. 1,500,000$1,680,0000.09%
SECTORAL ASSET MANAGEMENT INC 385,000$431,0000.09%
View complete list of MEREO BIOPHARMA GROUP PLC shareholders